Discussion and Analysis for the quarter 1 year 2018 To The President of the Stock Exchange of Thailand Management’s Discussion and Analysis Consolidated Financial Results for the quarter 1 year 2018 For the

Microsoft Word - MD&A_Q2_2018_ENG 1 NPPG.064/2018 14 August 2018 Subject Management Discussion and Analysis for the quarter 2 year 2018 To The President of the Stock Exchange of Thailand Management’s

14 November 2018 Subject: Management Discussion and Analysis for the Nine-Month Period Ended September 30, 2018 To: Directors and Managers The Stock Exchange of Thailand Halcyon Technology Public

and efficiency of the capital market. This will contribute to the robust and sustainable growth of the economy. We envision opportunities for developing the Thai capital market to support the

 In Q4/2017, the Company and its subsidiary recorded total sales of Baht 1,531 million, an increase of 2% YoY, following growth from domestic CMG launching new products as well as continue growth from

Recognising the crucial role sustainable economic growth plays in bringing about better living standards and inclusive economic development for all, in 2015 Thailand has adopted the United Nations

June 2019 To: The President The Stock Exchange of Thailand According to the resolution of the Board of Directors Meeting of Jaymart Public Company Limited ("the Company") No. 3/2019, held on 9 August

February 20, 2019 Re: Management Discussion and Analysis for full year 2018 To: Director and Manager of the Stock Exchange of Thailand Revenue from sales and rendering of services L&E’s consolidated

Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for year ended of 31 December 2017 as follows. The operation results

May 8, 2019 Re : Management Discussion and Analysis for Q1/2019 To : Director and Manager of the Stock Exchange of Thailand Revenue from sales and rendering of services L&E’s consolidated revenue